Urinary tract infections (UTI) represent the most common bacterial infections among patients
visiting outpatient clinics of healthcare centers in Nepal. However, treatment of such …

The prevalence of extended‐spectrum β‐lactamase‐producing Escherichia coli (ESBL‐
producing E. coli) has recently increased worldwide. This study aims at determining the …

Introduction: Multidrug resistance (MDR) and emergence of extended-spectrum β-
lactamases (ESBLs) that mediate resistance to b-lactam drugs among Escherichia coli and …

Background To determine the prevalence, phenotypes, and genotypes of extended
spectrum β-lactamase (ESBL)-producing Escherichia coli (E. coli) among patients with …

BACKGROUND: Recently, there has been a notable surge in urinary tract infections (UTIs)
by extended spectrum β-lactamase (ESBL)-producing Escherichia coli, which considerably …

Abstract Background and Objective: Urinary Tract Infections (UTIs) are mostly caused by
Escherichia coli. The appropriate therapy demands a current knowledge on the …

Aims: The present prospective study was done to identify the trends of uropathogens, to find
the prevalence of ESBL isolates and to study the antibiotic resistance profile of the ESBL …

Background. Klebsiella pneumoniae and Escherichia coli are the major extended‐spectrum
β‐lactamase‐(ESBL‐) producing organisms increasingly isolated as causes of complicated …

Objectives Antimicrobial resistance among uropathogenic Escherichia coli (UPEC) is
increasing. The aim of this study was to evaluate antimicrobial resistance in UPEC isolates …

Background and objectives: Multidrug-resistant E. coli expressing extended-spectrum β-
lactamase pose serious challenges to clinicians for the therapeutic management of clinical …